Pressure BioSciences, Inc.
PBIO
Rank in Stocks
#34458
Pressure BioSciences, Inc. develops and sells high pressure technology-based... Pressure BioSciences, Inc. develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide. The company’s products/services are based on Ultra Shear Technology platform, which turns hydrophobic oil-based supplements, therapeutics, and other active ingredients to water-soluble, bioavailable, oil-in-water nano emulsion formulations; BaroFold Technology platform, that is used to improve the quality and lower the production costs of protein biotherapeutics; and Pressure Cycling Technology platform which uses alternating cycles of hydrostatic pressure between ambient and ultra-high pressures to control bio-molecular interactions in sample preparation. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB440, Barocycler HUB880, and the Shredder SG3; Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, and PCT-Micro Pestle; UltraShear Mini, UltraShear K45, and UltraShear Max; and application specific kits, as well as consumable products. The company also provides pain relief, skincare solutions, personal wellness, athletic recovery, and specialized pet care products. It serves researchers at academic laboratories, government agencies, biotechnology and pharmaceutical companies, other life science institutions, and food/beverages laboratories. The company has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. Pressure BioSciences, Inc. was incorporated in 1978 and is headquartered in Canton, Massachusetts.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$10.28K
Change (1 day)
0.00%
Change (1 year)
-60.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Pressure BioSciences, Inc. (PBIO)
Category
Healthcare
EPS for Pressure BioSciences, Inc. (PBIO)
EPS as of June 2024 TTM: $-1.10
According to Pressure BioSciences, Inc.'s latest financial reports, its current EPS (TTM) is $-1.10. At the end of 2023 the company had an EPS of $-1.51, an increase over its 2022 EPS of $-1.61.
EPS history for Pressure BioSciences, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.10 | -27.15% |
| 2023 | $-1.51 | -6.21% |
| 2022 | $-1.61 | -52.92% |
| 2021 | $-3.42 | -35.71% |
| 2020 | $-5.32 | -33.33% |
| 2019 | $-7.98 | -47.95% |
| 2018 | $-15.33 | 59.42% |
| 2017 | $-9.62 | 220.57% |
| 2016 | $-3.00 | -72.22% |
| 2015 | $-10.80 | -18.18% |
| 2014 | $-13.20 | 0.00% |
| 2013 | $-13.20 | 2.33% |
| 2012 | $-12.90 | -44.16% |
| 2011 | $-23.10 | -42.96% |
| 2010 | $-40.50 | -4.93% |
| 2009 | $-42.60 | -36.61% |
| 2008 | $-67.20 | 101.80% |
| 2007 | $-33.30 | 9.90% |
| 2006 | $-30.30 | -448.28% |
| 2005 | $8.70 | -84.37% |
| 2004 | $55.67 | -1,080.11% |
| 2003 | $-5.68 | -15.22% |
| 2002 | $-6.70 | -139.88% |
| 2001 | $16.80 | -138.36% |
| 2000 | $-43.80 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.45 | -868.18% |
IE
|
|
| $0.21 | -118.95% |
CN
|
|
| $19.69 | -1,889.89% |
CH
|
|
| $4.34 | -494.36% |
CH
|
|
| $0.13 | -111.45% |
CN
|
Questions about Pressure BioSciences, Inc.'s earnings per share (EPS)
What is Pressure BioSciences, Inc.'s earnings per share (EPS)?
Pressure BioSciences, Inc.'s earnings per share (EPS) over the last twelve months is $-1.10, as of Jun 2024.
What was Pressure BioSciences, Inc.'s earnings per share (EPS) in 2023?
In 2023, Pressure BioSciences, Inc.'s earnings per share (EPS) was $-1.51, compared with $-1.61 in 2022.
How has Pressure BioSciences, Inc.'s earnings per share (EPS) changed since 2018?
From 2018 to 2023, Pressure BioSciences, Inc.'s earnings per share (EPS) was highest in 2023 ($-1.51) and lowest in 2018 ($-15.33).
How does Pressure BioSciences, Inc.'s earnings per share (EPS) compare with similar companies?
Pressure BioSciences, Inc.'s earnings per share (EPS) ($-1.10) is lower than that of all 5 similar companies listed above. The highest among them is Ypsomed Holding AG, with $19.69.